Chimeric antigen receptor (CAR) T-cell therapies have quickly moved from early phase clinical trials to FDA approval for diffuse large B-cell...
Day: 13 August 2018
Goy Discusses Maintenance, CAR T-Cell Therapy in MCL
Promising clinical trial data have highlighted advances in the treatment of mantle cell lymphoma (MCL), but an important next step is applying this...